BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22622506)

  • 1. [New methods of drug delivery through the blood brain barrier].
    Bruhn C
    Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
    [No Abstract]   [Full Text] [Related]  

  • 2. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
    Deeken JF; Löscher W
    Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
    Kreuter J
    J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using blood brain barrier disruption by methamphetamine for drug delivery.
    Kast RE
    J Neurooncol; 2007 Oct; 85(1):109-10. PubMed ID: 17464448
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic bases of chemotherapy of brain tumors in children].
    Vassal G
    Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V; Lee TY
    Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
    [No Abstract]   [Full Text] [Related]  

  • 12. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated platform for brain imaging and drug delivery across the blood-brain barrier.
    Iqbal U; Abulrob A; Stanimirovic DB
    Methods Mol Biol; 2011; 686():465-81. PubMed ID: 21082388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging and drug delivery to tumor-infiltrated brain.
    Black KL
    Clin Neurosurg; 1994; 41():563-72. PubMed ID: 7842624
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M; Fortin D
    Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic constraints imposed by the blood-brain barrier: the example of multiple sclerosis].
    Jolliet P
    Rev Neurol (Paris); 2000 Jul; 156(6-7):681-3. PubMed ID: 10891808
    [No Abstract]   [Full Text] [Related]  

  • 20. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
    Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
    Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.